Kyo Diagnostics
Plug and Play · Personalized healthcare business based on sensitivity testing on anticancer drugs for colorectal cancer.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCS21 | |
| Other | Not stated | Plug and Play | |
| Other | Not stated | 500 GlobalSaola | |
| Other | Not stated | Plug and Play |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW26 | |
| AI | Not stated | Plug and Play | |
| AI | Acquired | YCS15 | |
| Other | Not stated | 500 Global2022 | |
| Other | Active | YCS15 |
Also from Plug and Play
All of Plug and PlayPrograms
| Program | Cohort | Source |
|---|---|---|
| Not stated | Plug and Play Page |
About Kyo Diagnostics
"Kyo Diagnostics is a pioneering health and insurtech company specializing in personalized healthcare solutions. Utilizing advanced techniques to culture cancer stem cells from cancer tissue and Patient-Derived Spheroid Xenograft (PDSX) modeling technology, Kyo Diagnostics focuses on sensitivity testing for anticancer drugs, particularly for colorectal cancer. By offering tailored healthcare options based on individual patient needs and responses to treatment, Kyo Diagnostics aims to revolutionize cancer care and improve patient outcomes. The company's innovative approach to personalized medicine and drug testing showcases its commitment to advancing the field of oncology and providing cutting-edge solutions for patients and healthcare providers alike."
- Category
- Other
- Location
- Japan
- Checked
- 1h ago
Kyo Diagnostics: questions
Which accelerators did Kyo Diagnostics go through?
Kyo Diagnostics is listed by Plug and Play.
Where is Kyo Diagnostics based?
Kyo Diagnostics lists Japan as its location on Plug and Play's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.